Prospective, Open-Label, Observational, Multicenter, Single Arm, Post-Marketing Study in Asthmatic Patients for Evaluation of Safety and Effectiveness of Indacaterol/Mometasone DPI (PROMISING-SHIFT)
Once-daily IND/MF DPI demonstrated a favorable safety profile with marked improvements in lung function, asthma control, and patient satisfaction, making it a promising option for long-term asthma management in Indian patients.
Authors
- Amit Suresh Bhate
- Vijaykumar Bhagwan Barge
- Bharat Mehrotra
- Hanmant Barkate (ORCID: https://orcid.org/0000-0003-4346-9194)
- Chintan Patel (ORCID: https://orcid.org/0000-0002-6877-3363)
- Sagar Bhagat (ORCID: https://orcid.org/0000-0002-3513-4944)
- Saurabh Karmakar (ORCID: https://orcid.org/0000-0002-8138-4864)
- Gajendra Vikram Singh (ORCID: https://orcid.org/0009-0000-7350-4742)
- Saiprasad Patil (ORCID: https://orcid.org/0000-0002-4937-3188)
- Ekta Sinha
Institutions
- Sarojini Naidu Medical College (IN)
- Rajarshee Chhatrapati Shahu Maharaj Government Medical College and CPR Hospital Kolhapur (IN)
- Glenmark Pharmaceuticals (India) (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Advances in respiratory medicine
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3390/arm93010003
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00